These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2530774)

  • 41. No crossover reactions to citalopram or paroxetine among patients hypersensitive to zimeldine.
    Bengtsson BO; Lundmark J; Wålinder J
    Br J Psychiatry; 1991 Jun; 158():853-5. PubMed ID: 1831396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Femoxetine and amitriptyline in general practice: a randomized double-blind group comparison.
    Skrumsager BK; Jeppesen K
    Pharmacopsychiatry; 1986 Sep; 19(5):368-77. PubMed ID: 3774871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is there action beyond receptors?
    Hrdina PD
    J Psychiatry Neurosci; 1993 Mar; 18(2):57-9. PubMed ID: 8384874
    [No Abstract]   [Full Text] [Related]  

  • 44. A clinical profile of paroxetine: a novel selective serotonin reuptake inhibitor (SSRI).
    J Clin Psychiatry; 1992 Feb; 53 Suppl():1-68. PubMed ID: 1531815
    [No Abstract]   [Full Text] [Related]  

  • 45. [The comparative efficacy of Aurorix and amitriptyline in treating depressions].
    Iakovlev VA
    Voen Med Zh; 1997 Apr; 318(4):37-8. PubMed ID: 9221592
    [No Abstract]   [Full Text] [Related]  

  • 46. Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline.
    Montgomery SA; Montgomery DB; McAuley R; Rani SJ; Roy D
    Adv Biochem Psychopharmacol; 1982; 32():35-42. PubMed ID: 6211942
    [No Abstract]   [Full Text] [Related]  

  • 47. Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements.
    Nielsen OA; Morsing I; Petersen JS; Larsen T; Møller SE; Manniche PM; Skausig OB
    Acta Psychiatr Scand; 1991 Sep; 84(3):233-41. PubMed ID: 1835251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Depression and selective serotonin reuptake inhibitors.
    Westwick F
    Br J Hosp Med; 1990 Nov; 44(5):367. PubMed ID: 2148896
    [No Abstract]   [Full Text] [Related]  

  • 49. New antidepressants and trends in the pharmacotherapy of depressive disorders.
    Zarifian E; Rigal F
    Psychiatr Clin North Am; 1983 Mar; 6(1):129-39. PubMed ID: 6889169
    [No Abstract]   [Full Text] [Related]  

  • 50. The electrocardiogram as a tool for therapeutic monitoring: a critical analysis.
    Guy S; Silke B
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():37-9. PubMed ID: 2258381
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new antidepressant agent: amitriptyline-N-oxide.
    Borromei A
    Adv Biochem Psychopharmacol; 1982; 32():43-7. PubMed ID: 7046367
    [No Abstract]   [Full Text] [Related]  

  • 52. [Open preliminary study of new antidepressive compound: citalopram].
    Ropert R; Lôo H; Gay C
    Encephale; 1984; 10(3):131-4. PubMed ID: 6594229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Paroxetine: pharmacokinetic and antidepressant effect in the elderly.
    Lundmark J; Scheel Thomsen I; Fjord-Larsen T; Manniche PM; Mengel H; Møller-Nielsen EM; Pauser H; Wålinder J
    Acta Psychiatr Scand Suppl; 1989; 350():76-80. PubMed ID: 2530794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recovery from depression: triggers and time patterns.
    Parker G
    Aust N Z J Psychiatry; 1996 Aug; 30(4):442-4. PubMed ID: 8887691
    [No Abstract]   [Full Text] [Related]  

  • 55. A placebo-controlled, double-blind, clinical trial of paroxetine in depressed outpatients.
    Rickels K; Amsterdam J; Clary C; Fox I; Schweizer E; Weise C
    Acta Psychiatr Scand Suppl; 1989; 350():117-23. PubMed ID: 2530761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sociotropy and autonomy: relationship to antidepressant drug treatment response and endogenous-nonendogenous dichotomy.
    Peselow ED; Robins CJ; Sanfilipo MP; Block P; Fieve RR
    J Abnorm Psychol; 1992 Aug; 101(3):479-86. PubMed ID: 1386856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB; Crowder JE; Wilcox CS; Ryan PJ
    Psychopharmacol Bull; 1990; 26(2):185-9. PubMed ID: 2146697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tolerability and safety aspects of mirtazapine.
    Nutt DJ
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S37-41. PubMed ID: 12404669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A double-blind study of minaprine versus amitriptyline in major depression.
    Del Zompo M; Bernardi F; Burrai C; Bocchetta A
    Neuropsychobiology; 1990-1991; 24(2):79-83. PubMed ID: 2134115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of depressive disorders].
    Saiz Ruiz J; Ibáñez Cuadrado A
    Rev Clin Esp; 1997 Nov; 197 Suppl 3():35-43. PubMed ID: 9477689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.